Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 88.60
-0.50 (-0.56%)
Nov 11, 2026, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 83.39 billion as of November 10, 2026. It is the 2,075th most valuable company in the world and the 115th biggest in Hong Kong. Its market cap has decreased by 21.35% in one year.
Market Cap
83.39B
Enterprise Value
78.42B
Revenue
3.98B
Global Rank
Country Rank
#115 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 83.39B, an increase of 349.66%. That is a compound annual growth rate of 25.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 83.39B | -19.89% |
| Dec 31, 2025 | 104.09B | 91.05% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 197.72B |
| Innovent Biologics | 148.85B |
| Sichuan Kelun-Biotech Biopharmaceutical | 108.04B |
| Sino Biopharmaceutical | 97.51B |
| Genscript Biotech | 73.20B |
| RemeGen | 54.69B |
| 3SBio | 36.76B |
| Biocytogen Pharmaceuticals (Beijing) | 34.62B |